[FATTY LIVER PATHOGENESIS IN CARASSIUS AURATUS IN GLUCOSE-RICH MEDIUM AND ITS ALTERATION BY N1-N-BUTYLBIGUANIDE AND N'-(4-METHYLBENZOYLSULFONYL)-N'-BUTYLUREA (TOLBUTAMIDE)].
D000818:Animals; D002026:Buformin; D004040:Dietary Carbohydrates; D005234:Fatty Liver; D005399:Fishes; D005947:Glucose; D006054:Goldfish; D006529:Hepatomegaly; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D010600:Pharmacology; D012106:Research; D014044:Tolbutamide; D014508:Urea / Q000031:analogs & derivatives
D004040:Dietary Carbohydrates; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D014508:Urea; D014044:Tolbutamide; C006865:butylurea; D005947:Glucose; D002026:Buformin
ANTIDIABETICS; DIETARY CARBOHYDRATES; EXPERIMENTAL LAB STUDY; FATTY LIVER; FISHES; GLUCOSE; HEPATOMEGALY; LIVER GLYCOGEN; PHARMACOLOGY; TOLBUTAMIDE
FETTLEBER-ENTSTEHUNG BEI CARASSIUS AURATUS IN GLUKOSEREICHEM MILIEU UND DEREN  BEEINFLUSSUNG DURCH N1,N-BUTYLBIGUANID SOWIE N-SULFANILYL-N'-BUTYLHARNSTOFF (TOLBUTAMID)